206 related articles for article (PubMed ID: 33541259)
1. Increased expression of MUSASHI1 in epithelial breast cancer cells is due to down regulation of miR-125b.
Forouzanfar M; Lachinani L; Dormiani K; Nasr-Esfahani MH; Ghaedi K
BMC Mol Cell Biol; 2021 Feb; 22(1):10. PubMed ID: 33541259
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
3. The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.
Vo DT; Qiao M; Smith AD; Burns SC; Brenner AJ; Penalva LO
RNA Biol; 2011; 8(5):817-28. PubMed ID: 21881409
[TBL] [Abstract][Full Text] [Related]
4. miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.
Shi C; Zhang Z
Tumour Biol; 2016 Apr; 37(4):5437-43. PubMed ID: 26563371
[TBL] [Abstract][Full Text] [Related]
5. miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.
Feliciano A; Castellvi J; Artero-Castro A; Leal JA; Romagosa C; Hernández-Losa J; Peg V; Fabra A; Vidal F; Kondoh H; Ramón Y Cajal S; Lleonart ME
PLoS One; 2013; 8(10):e76247. PubMed ID: 24098452
[TBL] [Abstract][Full Text] [Related]
6. Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival.
Wang XY; Penalva LO; Yuan H; Linnoila RI; Lu J; Okano H; Glazer RI
Mol Cancer; 2010 Aug; 9():221. PubMed ID: 20727204
[TBL] [Abstract][Full Text] [Related]
7. Antagonism between the RNA-binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma development.
Velasco MX; Kosti A; Guardia GDA; Santos MC; Tegge A; Qiao M; Correa BRS; Hernández G; Kokovay E; Galante PAF; Penalva LOF
RNA; 2019 Jul; 25(7):768-782. PubMed ID: 31004009
[TBL] [Abstract][Full Text] [Related]
8. Mir-23a and mir-125b regulate neural stem/progenitor cell proliferation by targeting Musashi1.
Gioia U; Di Carlo V; Caramanica P; Toselli C; Cinquino A; Marchioni M; Laneve P; Biagioni S; Bozzoni I; Cacci E; Caffarelli E
RNA Biol; 2014; 11(9):1105-12. PubMed ID: 25483045
[TBL] [Abstract][Full Text] [Related]
9. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.
Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y
Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964
[TBL] [Abstract][Full Text] [Related]
10. Intracellular functions of RNA-binding protein, Musashi1, in stem and cancer cells.
Forouzanfar M; Lachinani L; Dormiani K; Nasr-Esfahani MH; Gure AO; Ghaedi K
Stem Cell Res Ther; 2020 May; 11(1):193. PubMed ID: 32448364
[TBL] [Abstract][Full Text] [Related]
11. Musashi1 Promotes Non-Small Cell Lung Carcinoma Malignancy and Chemoresistance via Activating the Akt Signaling Pathway.
Lang Y; Kong X; He C; Wang F; Liu B; Zhang S; Ning J; Zhu K; Xu S
Cell Physiol Biochem; 2017; 44(2):455-466. PubMed ID: 29141252
[TBL] [Abstract][Full Text] [Related]
12. Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.
Nakanishi H; Taccioli C; Palatini J; Fernandez-Cymering C; Cui R; Kim T; Volinia S; Croce CM
Oncogene; 2014 Feb; 33(6):702-12. PubMed ID: 23416980
[TBL] [Abstract][Full Text] [Related]
13. Msi1 promotes tumor progression by epithelial-to-mesenchymal transition in cervical cancer.
Gong P; Wang Y; Gao Y; Gao M; Liu L; Qu P; Jin X; Gao Q
Hum Pathol; 2017 Jul; 65():53-61. PubMed ID: 28088346
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells.
Tang F; Zhang R; He Y; Zou M; Guo L; Xi T
PLoS One; 2012; 7(5):e35435. PubMed ID: 22693547
[TBL] [Abstract][Full Text] [Related]
15. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
18. miR-125b-5p inhibits breast cancer cell proliferation, migration and invasion by targeting KIAA1522.
Li Y; Wang Y; Fan H; Zhang Z; Li N
Biochem Biophys Res Commun; 2018 Sep; 504(1):277-282. PubMed ID: 30177391
[TBL] [Abstract][Full Text] [Related]
19. The oncogene Musashi1 encodes novel miRNAs in breast cancer.
Lachinani L; Forouzanfar M; Dormiani K; Soltani BM; Dolatshahi K; Hakimian SM; Dokanehiifard S; Nasr-Esfahani MH
Sci Rep; 2023 Aug; 13(1):13710. PubMed ID: 37607966
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
